Question 1

Who are the top researchers at Intezyne (United States)?

Accepted Answer

Ranked on the quality score, Suzanne J. Bakewell, Kevin Sill and Tomáš Vojkovský lead among researchers whose main affiliation is Intezyne (United States).

Question 2

What are the most cited papers from Intezyne (United States)?

Accepted Answer

The most cited paper from Intezyne (United States) is "Safety and activity of IT-139, a ruthenium-based compound, in patients with advanced solid tumours: a first-in-human, open-label, dose-escalation phase I study with expansion cohort" (Howard A. Burris, Suzanne J. Bakewell, Johanna C. Bendell et al., 2016), with 157 citations. Next come "A Versatile Polymer Micelle Drug Delivery System for Encapsulation and In Vivo Stabilization of Hydrophobic Anticancer Drugs" (53) and "Suppression of stress induction of the 78-kilodalton glucose regulated protein (GRP78) in cancer by IT-139, an anti-tumor ruthenium small molecule inhibitor" (52).

Question 3

Which research topics does Intezyne (United States) publish most on?

Accepted Answer

By volume: Nanoparticle-Based Drug Delivery, RNA Interference and Gene Delivery, Nanoplatforms for cancer theranostics and Advanced biosensing and bioanalysis techniques.

Question 4

Which fields of science does Intezyne (United States) work in?

Accepted Answer

In all years, 43% of research at Intezyne (United States) is in Life Sciences, 36% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (43%), Medicine (22%), Materials Science (17%). It does 1.8× the world's share of Life Sciences.

Question 5

Is Intezyne (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.